Skip to main content
OpenTrials

Clinical trial condition

Smoldering Plasma Cell Myeloma

Explore clinical trials studying Smoldering Plasma Cell Myeloma. Study availability and eligibility vary by location and protocol.

11 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Smoldering Plasma Cell Myeloma trial results

Recruiting

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

NCT03937635

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 747 locations
View Trial Details
Active, Not Recruiting

Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients

NCT05014646

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Atrium Health University City/LCI-University Charlotte, North Carolina, United States
View Trial Details

Related conditions